Searched for
IQVIA HOLDINGS
US stocks: S&P 500 ends higher as investors await tech earningsThe S&P 500 index closed higher on Tuesday, boosted by gains in Boeing and Coca-Cola. Chip stocks experienced a significant decline as inve...- Trump & Co said to have shelved generic drug tariffs, Indian pharma stocks get booster doseThe Trump White House has halted plans for tariffs on generic drug imports, a decision welcomed by Indian pharma companies that supply near...
- Lupin shares gain 2% after USFDA approval for HIV drugLupin's shares surged by 2.2% following tentative U.S. FDA approval for its generic HIV treatment, Bictegravir, Emtricitabine, and Tenofovi...
- Zydus Lifesciences shares in focus after USFDA nod for Celecoxib capsulesZydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will manufacture the drug...
- Lupin shares in focus after FDA nod for post-eye surgery drug Loteprednol Etabonate GelShares of Lupin are set to be in focus after it received US FDA approval for its generic Loteprednol Etabonate Ophthalmic Gel, granting it ...
- Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from WockhardtSenores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migrai...
- Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drugZydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last week's approval for...
- Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...
- Gland Pharma shares rise 5% on receiving US FDA approval for vitamin K deficiency injectableGland Pharma shares rose after receiving FDA approval for phytonadione injectable emulsion, a product used for coagulation disorders. Despi...
- Sales of Electral jump 26% in hottest April on recordIndia's pharma market took a dip in March after poor sales of respiratory and anti-infective therapies dropped post-winter. April saw the m...
- Top stock to buy: Aurobindo Pharma has returned a whopping 126.3% in one yearAnalysts are bullish on Aurobindo Pharma due to the buoyant growth prospects of pharma industry and the company’s strong strategic investme...
- Midcap stock zooms 9% on receiving USFDA approval for glaucoma drugBrimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressu...
- Lupin shares surge 5% on receiving USFDA approval for Valbenazine CapsulesLupin is a pharmaceutical company headquartered in Mumbai, India. While, it is the third-largest pharmaceutical company in the US by prescr...
- Buy Natco Pharma, target price Rs 1021: ICICI SecuritiesNatco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 15529.31 Crore) operating in Pharmaceutic...
- Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivityZydus was the first abbreviated new drug application (ANDA) filer on Tofacitinib extended-release tablets 22 mg and thus holds 180-day excl...
- Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
- Sun Pharma rallies 4% on licensing agreement with China’s CMSCollaboration with CMS now covers eight generic products including these seven products.
- Strides inks JV pact with China's Sihuan PharmaSihuan will leverage its over 4,000 strong sales force and 3,000 plus distributors across Mainland China to market the products.
- Lupin launches generic antidepressant tablets in USThe company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food a...
- Govt seeks help from IT biggies to make Ayushman insurance scheme fraud freeIT firms have been called on to build a shield that can identify "suspicious" PMJAY transactions.
Load More
